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As influenza H1N1 spreads around the world, health officials are considering the development
and use of a new vaccine to protect the public and help control the outbreak. Acceptance
of novel vaccines during health crises, however, is influenced by perceptions of a range of
risks, including the risk of infection, risk of becoming severely ill or dying if infected, as well as
the risk of serious side and long-term effects of the vaccine. A study on 11 focus groups was
conducted with the public in Vancouver, Canada in 2006 and 2007 to explore how people
assess these risks and how these assessments relate to their willingness to use novel vaccines in
a pandemic. Concerns about using new vaccines during a pandemic differ from concerns
about using established products in a non-crisis situation. Participants were hesitant to use
novel vaccines because of a low perception of the early risk of infection in a pandemic, coupled
with the many uncertainties that surround new vaccines and the emerging infectious disease,
and owing to the concern that unsafe pharmaceuticals may be rushed to market during a health
crisis. Understanding the public’s assessment of the risks related to, and willingness to use,
novel vaccines during a pandemic can help officials promote disease-control measures in
ways that improve the likelihood of acceptance by the public and may increase uptake of an
H1N1 vaccine.
Introduction
Public health officials have been worried for some time
about the imminent threat of an influenza pandemic, either
the influenza A H5N1 virus or, most recently, the H1N1
virus.
1,2 Although a specific pandemic virus could not be
anticipated with certainty, it was important to understand
how the public may react to a pandemic in advance of the
crisis and then apply the findings during an actual outbreak,
at which point public health emphasis focuses on disease
control and treatment rather than on qualitative research
with the public. One question addressed during the pre-
pandemic period was how the public may perceive new
vaccines for use in a pandemic. At present, as health
agencies, the WHO and drug companies work together to
develop a vaccine for the H1N1 virus,
3,4 we can draw on this
research to answer the question: What influences a person’s
decision to get vaccinated with a novel vaccine in the event
of a pandemic? Assuming a vaccine is developed, a campaign
to vaccinate all or large segments of a society will be effective
only if the public is willing to get vaccinated.
Decision making regarding the use of vaccines is, in
part, influenced by how the public assesses the risks asso-
ciated with a disease (how likely they are to become
infected and how sick they may become if infected) and
the vaccine. Little is known, however, with regard to
the manner in which the decision-making process is
affected by the uncertainties associated with a new disease
and new vaccines that would be developed to control it.
These uncertainties are especially great early on in a
pandemic when very little may be known about the disease,
about at-risk populations and about the effectiveness
and safety of control mechanisms. In this case, under-
standing how vaccination decisions may be made in the
event of a pandemic will help to develop strategies to
increase the likelihood of compliance with vaccination
recommendations.
Methods
A study on 11 focus groups with a total of 85 members of
the public was conducted in Vancouver, BC, Canada
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study was to ascertain the attitudes, concerns and percep-
tions regarding the risk of emerging infectious diseases
(EIDs) and the use of new vaccines. Focus groups were
the chosen methodology because the format allows for
broad discussions and interactions that can hone the
development of topics for qualitative surveys with larger
populations. Ethics approval for the research was received
from the University of British Columbia’s ethics review
board.
Participants
Participants for the focus groups included the following,
selected to represent a broad spectrum of opinions and
perspectives:
  two groups of university students;
  three groups of adult Canadians, including one group
each from the Chinese community, new immigrants and
non-ethnic Canadians;
  three groups of parents: two groups known to be skeptical
of, or opposed to, childhood vaccinations because of
their non-mainstream or ‘alternative’ beliefsFwe refer
to these as ‘alternative’ parent groups; one group from
a ‘mainstream’ community that is believed to have
societally predominant attitudes about childhood
vaccinationsFwe refer to this group as ‘mainstream’
parents;
  three groups of health-care workers (HCWs): this group
included any health-care professional working for the
Vancouver Coastal Health Authority, with participants
representing a diverse array of occupations such as nurses,
physiotherapists, social workers, health administrators
and health educators.
Note that participants in any of the groups could be
parents, but all participants in the parent groups were
required to be parents in order to participate in those
sessions.
The Chinese community was targeted because Chinese
people make up 43.6% of the visible minority population
in Vancouver and 19.2% of Vancouver’s total population.
No other visible minorities constitute nearly as large a
percentage of the population.
5 Participants in this group
self-identified themselves as Chinese and were recruited
from a Chinese community center. The new immigrant
group was included in the study because we speculated
that recent immigrants from countries outside of Western
Europe and North America may not be acculturated
into, or fully accessing, the biomedical health-care
system and consequently may be less likely to use
vaccines.
6–9
University students were included because of the impor-
tance of vaccinating students during an outbreak, given this
population’s high number of close social contacts both
in the classroom and in their group living environments.
As students’ decisions often diverge from those of non-
student adults in their populations,
10–14 we could not
assume that information obtained from non-student adults
would reflect students’ perspectives.
Parents were targeted because they would be making
decisions regarding vaccination for their children, as
well as for themselves. The ‘alternative’ parents were
included because it is known that alternative health-
care providers (for example, homeopaths, naturopaths
and chiropractors) tend to recommend that their patients
refuse vaccinations,
15–17 and this population could pose a
threat to the public’s health if they refuse to vaccinate
themselves or their children during a pandemic. The ‘main-
stream’ parents served as a control for the ‘alternative’
parents and represented the majority of parents in the
population.
HCWs were included because they would be involved in
vaccinating people during a pandemic and, potentially, in
educating patients about the vaccines.
Recruitment
Participants were recruited with an email and/or flyer.
One group of students was also recruited with an announce-
ment made in a large, multi-discipline undergraduate
class and one group of ‘alternative’ parents was recruited
by posting our recruitment email on a parent listserv
known to be used by parents who have non-tradi-
tional attitudes about health and other social issues.
HCWs were recruited by sending a recruitment email
to all employees of the Vancouver Coastal Health
Authority.
All participants, except HCWs, received an incentive
of $25, which was equivalent to approximately double
the local minimum wage at the time of the study. HCWs
received $40, which was calculated by averaging a typical
hourly wage for nurses and new physicians.
Procedure
Each focus group discussion lasted approximately one and
a half hours and was audio taped. At the beginning of each
session, the leader described a fictitious disease. Participants
were informed that a new, sometimes deadly, disease had
developed in India that caused symptoms including
bloody diarrhea, severe headaches, muscle and joint pain,
and as the disease progresses, difficulty in breathing, and
that the disease was spreading from person to person but
had not yet spread outside of India. It was stated explicitly
that this was a fictitious disease. The group was then asked
questions regarding (1) their perceptions of risk as the
disease spread around the world and eventually arrived
in Vancouver, and (2) their concerns, questions and atti-
tudes about, and willingness to use, hypothetical new
vaccines developed to prevent the disease. The issue
of how the novelty of the disease and the vaccine
may impact attitudes and behaviors was queried in each
group.
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Focus group recordings were transcribed and uploaded
to QSR-Nvivo7 for coding and qualitative analysis. A two-
pronged approach was taken for the coding. One set of codes
was selected on the basis of research questions, capturing
topics that we determined a priori and that we wanted to
learn about. A second set of codes captured themes and
concepts emerging in the discussions that we did not
necessarily anticipate. The codes were developed and
reviewed by both researchers. All coding was carried out by
one individual to ensure consistency, and the coded
transcripts were reviewed by the other researcher. Analyses
were performed by reviewing all conversations within a
given code or cluster of codes for a topic. Each focus group
was reviewed separately so that differences across focus
group populations could be detected. Frequencies of discus-
sion content were tracked to determine which of the
comments, attitudes, concerns, etc. were expressed most
frequently and which were rare, and to assess whether a
different content was expressed with differential frequency
across groups. Conclusions were drawn on the basis of the
content and frequency of the discussion comments for a
topic.
Results
The findings from the focus groups presented in this section
represent opinions that were commonly expressed across
focus groups. If a finding/quotation characterizes a minority
opinion or occurred in only one or a few of the groups, it is
specifically indicated.
Risk of infection
Proximity and ease of spread
When the disease was still confined to its country of origin,
most participants said they would have minimal concern
about their personal risk of infection and many would
simply monitor the disease’s progress. Representative
comments include:
I would be interested but I wouldn’t be worried. Like I’d
follow it but I wouldn’t be worried, worried. I’d be
interested to find out what happened, I guess. [Student]
I would stay informed actuallyy.My awareness would
be heightened. [‘Alternative’ parent]
In all groups, except for the ‘alternative’ parents, at
least some individuals felt they would be at risk if the
disease was only in its country of origin. In the new
immigrant group, one of the student groups and one
of the HCW groups, all but one participant in each
group felt they would be at risk. In contrast, of the
participants in the two groups of ‘alternative’ parents,
only one person felt at-risk (others felt either no risk or
monitored the situation).
People who felt at-risk tended to focus on the great
amount of international travel that goes on today and
several people made reference to other diseases that have
spread rapidly around the world.
Because the, I think if the illness can spread easily from
one country to another country. Like AIDS. I remember
that AIDS, first time came from monkey also. And, then
spread it very fast in all continents and countries and
also SARS and Avian Flu. [New immigrant]
Among those who did not have any concern about
the disease when it was contained in its country of
origin, explanations included references to other diseases
that emerged outside Canada and never reached here, and
the possibility that, as the disease had not yet left India,
perhaps it never would.
Well the Avian Flu has been in the Asian countries for
a number of years now, and I don’t think there has
been a recorded case here in [Canada]. [HCW]
Overall, people’s level of perceived risk of infection
increased as we described scenarios in which the disease
moved ever closer to home. This was captured succinctly by
an HCW, who said, ‘The more it spreads, the more my
concern would increase. It would just be a direct ratio.’
Although many were adamant that they would not
panic or feel a high level of personal risk, a few people
said that they would begin to feel alarmed when the
disease arrived in BC. For parents, panic or great apprehen-
sion tended to relate to concerns about their children’s
health.
Immunity
Unlike participants in other groups, the ‘alternative’
parents remained largely unconcerned about the disease,
even as it spread. Only two of these parents were worried
about being infected, even as the disease arrived in
North America. The primary reason for these parents’ lack
of concern was their belief that being in good health
and eating well would give them a strong immune system
that prevents infection.
I also think thatFI heard this quote that Louis Pasteur
on his deathbed said, ‘the microbe is nothing, the
terrain is everything’ and I would be really like getting
rid of the sugar, okayya super healthy immune system
would be the way I would want to go. [‘Alternative’
parent]
Although it was mentioned less often outside of the
‘alternative’ parents group, other participants raised the
issue of the strength of a person’s immune system. These
people were not worried about contracting the disease
because they were healthy and because they believed that
the disease would probably affect only elderly people and
others with compromised immune systems.
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In all the groups, there were participants who believed that
they could adopt measures to protect themselves from
getting infected, such as handwashing and staying away
from crowded places and sick people, and for HCWs, by
following ‘universal precautions’ such as wearing masks and
being cautious of needles. The strong belief that people can
mitigate, if not control, the risk of becoming infected was
expressed in comments such as the following:
I have faith. I have faith in our personal hygieney
[Non-ethnic Canadian]
A lot, well all of us probably practice basic body, blood,
fluid precautions, right?...So, we’re equipped in that way
to handle new diseases. We know how to protect
ourselves. At least we think we do. [HCW]
Information and media
Participants’ perception of the risk of infection is largely
influenced by the information they receive about the
disease. Many of the participants stated that having
information about factors such as modes of transmission,
groups of people who are at greatest risk of infection, severity
of the illness and risk of death, and how the disease can be
prevented or treated would enable them to make better
informed decisions and give them a sense of control. In
contrast, uncertainty breeds fear and an elevated perception
of risk. As a non-ethnic Canadian explained, ‘I think the less
information the more hysteria you have around the whole
issue. So, the more information, the better you’re able to
analyze the risks.’
It was suggested by participants in seven focus groups that
the media could increase fear about the new disease simply
because they would be covering the story extensively.
Constant coverage of the situation would lead people to
assume that the threat was highly independent of any other
facts about the disease or the pandemic. As a ‘mainstream’
parent said, ‘If it’s something that was constantly in the
media, I probably would be more concerned about it than
other things just because of that perception, that’s it a more
dramatic thing, I think.’ Some participants believed that the
media would hype the situation and induce greater fear.
These sentiments were expressed in the following sessions:
two ‘alternative’ parent groups, the ‘mainstream’ parent
group, two student groups, one HCW group and the non-
ethnic Canadian group. The new immigrant, Chinese
community and two of the HCW groups did not mention
it, although all but the new immigrant group raised issues
about unreliability or mistrust of the media.
Novelty of disease
Participants generally shared the belief that they would feel
more threatened by an emerging disease than by an
established one. This elevated risk perception was due to
the many unknowns of a new disease, the susceptibility of
the population to infection, as well as because of a lack of
prevention and treatment measures. People seem to associ-
ate a danger with an EID that they do not feel for diseases
that have afflicted our population for many years. References
were made, for example, to the greater threat of an EID than
of tuberculosis or chicken pox.
Use of novel vaccines
In the context of the fictitious disease, participants were
asked whether, if a new vaccine were developed, they would
get vaccinated or have their children vaccinated. Very few
people said they would definitely get vaccinated.
Safety
The most influential factor in determining vaccination is
the safety of a new vaccine, especially one that is developed
rapidly in response to a health crisis. Participants were
greatly concerned that, in a pandemic, a vaccine would be
brought to market without sufficiently testing for safety.
But the one thing that I have never understood about,
you know, this idea of developing vaccines for a new or
emergent threat, how do they have time to go through
all the testing that they usually go through for vaccines
if it is suchFum, like, an immediate sort of need. How
do they do that and do they do that? [‘Alternative’
parent]
Participants were extremely hesitant to be the first users of
a product. There was a shared belief that there could be
problems with the safety of the vaccine that would only
surface after it has been used by many people and with
sufficient time for long-term effects to emerge. Across the
focus groups, participants felt that if they used a novel
vaccine they would be guinea pigs.
And I think that just given that the short time frame,
whatever a year, in which this disease has emerged, I
would be really quite wary of how they’d be able to have
significant clinical trials in that amount of time and
have proven that there aren’t any side-effects in 10
years, 5 years. You never know till your children. So I
would be kind of wary about that. [Student]
Hesitancy with regard to getting vaccinated with a new
vaccine does not reflect an overall distrust or dislike of
vaccines; wariness was related specifically to the novelty of
the vaccine.
Severity of morbidity from infection
In conjunction with considering vaccine safety, focus group
participants said they would base vaccination decisions
largely on the severity of morbidity if they were to become
infected. When deciding whether to get vaccinated, people
basically want to know how sick or impaired they would
become from the vaccine and whether they would become
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they would weigh information about issues such as how long
they would be sick and how debilitating the illness is against
the possibility and severity of side and long-term effects from
the vaccine. These sentiments were captured by an ‘alter-
native’ parent who said that in order to make a vaccine-use
decision she would want to know about:
Side-effects, any sort of long-term side-effects that they
might thinkFI guess the pros and cons versus using it
and not using it. I think probably would want to know a
lot more about the disease as well, not specifically just
the vaccine, but find out as much as possible about the
disease, the severity and longevity.
Similarly, an HCW explained: ‘Information would be key
and I’d have to weigh the cost and the benefit ofy I’d have
to know what would be the implications of getting the
disease. And what would be the implications of getting the
vaccine.’
Transmission
Part of the consideration for vaccination depends on the
mode of disease transmission, with people being most
willing to use a vaccine for an airborne disease. For
respiratory transmission, people felt that they have no way
to protect themselves, hence the risk of infection is greater
than that with other modes of transmission. In contrast,
people felt they have a lot of control regarding whether they
could contract a disease that spreads sexually, and even
HCWs were not overly concerned about blood-borne
diseases because they could protect themselves using proper
precautionary measures.
Children versus adults
Parents in the focus groups assessed the risks of novel
vaccines and EIDs differently for themselves than for their
children. A minority of parents said that they would
prioritize vaccinating their children, especially if the disease
could cause serious morbidity or death. Overwhelmingly,
parents claimed that they were more likely to vaccinate
themselves than their children. This reflects their belief that
the vaccine’s side-effects, and especially the long-term
effects, pose a greater risk than the disease. They were
willing to take on the risk of vaccinating themselves but felt
that it was more prudent to withhold the vaccine from their
children. Particularly with long-term effects, parents indi-
cated that because the children were young, there were
many more years for currently unknown long-term effects to
develop in their children than in themselves.
I guess I have more responsibility for [my child] and his
well being and his life. I don’t know. I guess I am just
a little bit more blase ´ with things I do to myself than
I might do to him. Things that I take for myself that
I might not do for him. [‘Alternative’ parent]
I think it would be different for me to vaccinate myself
rather than my children. Because I mean, I feel like, I feel
like, you know, I’d probably have a better immune
system. But to expose my children to something that is
absolutely brand new, I don’t know. I would hesitate.
[‘Mainstream’ parent]
The ‘mainstream’ parents were not generally opposed to
vaccinating their children; eight out of the nine parents in
this group had had their children vaccinated. However, they
perceived the risks of a novel vaccine as being much greater
than those for the standard set of childhood vaccines that
have been around for years. The ‘alternative’ parents tended
to be wary of any vaccinesFold or newFand their
unwillingness to vaccinate their children with the new
vaccine reflects their overall rejection of vaccines. Among
the ‘alternative’ parents, three had had their children
vaccinated with all the recommended vaccines and the rest
had either had some of their children partially vaccinated or
none at all.
Alternative medicine
Some participants’ decision to use novel vaccines was
influenced by the recommendations of alternative health
professionals. These people sought alternatives to vaccines,
which reflects their general preference for ‘natural’ treat-
ments rather than a specific rejection of novel vaccines. The
influence of alternative health professionals was particularly
prevalent among the ‘alternative’ parent groups, who
consult homeopaths or naturopaths for alternatives to
biomedical products and seek their advice on which
products to use. They also consult alternative health
professionals and nutritionists to help maintain good health
so as to avoid infection by EIDs.
Participants in the Chinese community and new immi-
grant groups, as well as one person in the ‘mainstream’
parent group, also said that they prefer to explore alter-
natives (in the form of Chinese medicine or naturopathy).
Individuals who consult alternative health professionals
would not reject biomedical treatment, but they would not
necessarily use it first or they may use it on the recommen-
dation of their alternative health professional.
Pharmaceutical companies
A theme that recurred across the focus groups was not
specific to novel vaccines but rather to vaccines in general-
Fthe motivation of the vaccine developers and of the
person conducting the research on the safety and efficacy
of the vaccine. Specifically, people expressed a distrust of
vaccines developed by pharmaceutical companies because
these companies may be motivated more by money than by
public health, which could lead to the marketing of vaccines
that are not safe, are ineffective or are just not really needed.
Similarly, some participants were more willing to use
vaccines that had been tested by independent researchers
rather than those that were funded by a pharmaceutical
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developed and tested by pharmaceutical companies, but
rather that they would have heightened concern. This
concern regarding pharmaceutical companies was raised by
a group of ‘alternative’ parents, both student groups, the
‘mainstream’ parent group, two of the HCW groups and by
the non-ethnic Canadian group. One ‘mainstream’ parent
and one HCW defended the pharmaceutical companies and
the quality of their products.
Discussion
The 2009 H1N1 outbreak began near the tail end of the usual
flu season. It is speculated that this strain of flu will return
during the next flu season.
18 This provides a brief window of
opportunity to produce and administer a vaccine for the
disease. Drawing on the findings from the focus group
discussions about the use of novel vaccines during a
pandemic, it can be anticipated that public health officials
will face several challenges in promoting vaccine uptake for
H1N1. First, given that the public believes that they have
control over whether they could become infected, it will be
necessary to promote the use of personal control measures,
such as frequent handwashing, covering your mouth when
coughing or social distancing, while at the same time
making it clear that these important preventive measures
are not sufficient and that vaccination is still necessary and
beneficial both for individuals and for the community.
19
Second, the public wants information about the disease
and the vaccine in order to make informed decisions about
vaccination. However, making this information widely
available needs to be balanced against providing too much
media coverage to the pandemic, which can incite fear
simply because frequent coverage is perceived to mean that
the situation is grave.
20
Third, it is imperative to communicate with alternative
health professionals and discuss the merits and risks of
vaccination for protecting individuals and controlling the
pandemic. The inclusion of alternative health professionals
is especially important because they often discourage
patients from using vaccines.
16,21,22 This segment of the
health profession should not be overlooked; in the United
States, for example, approximately 57% of the population
uses alternative therapies and 10% receives services from
alternative health-care providers;
23 thus, the influence on
their patients can mean the difference between whether or
not herd immunity is achieved.
Fourth, given the high degree of suspicion expressed by
focus group participants about the integrity and trustworthi-
ness of pharmaceutical companies, vaccines may be more
likely to be accepted by the public if they are developed in
conjunction with academic institutions or the government.
Finally, it is important to identify and address the diverse
concerns and perspectives of different groups in a popula-
tion.
20 Targeted communication strategies that address the
specific needs and attitudes of different segments of the
population may lead to greater vaccine acceptance than a
one-size-fits-all message. For example, on the basis of the
focus groups, we identified the ‘alternative’ parents’ low
perception of their risk of infection and their strong belief
that boosting their immunity would provide protection that
could make vaccination unnecessary, whereas other parents
had specific concerns about how the long-term side effects of
vaccines could affect their children. Ideally, subgroup
differences should be identified before initiating a vaccina-
tion campaign so that communications can be targeted right
from the beginning, rather than as a means of boosting
vaccination rates belatedly in groups that vaccinate at low
rates.
Limitations of the study
(1) The focus group participants are not representative of all
members of the population to which they belong, and
consequently the results are not generalizable.
(2) Although efforts were made to recruit men and women,
participants were mainly female (nfemales¼72 (85%);
nmales¼13 (15%)). Given that it is the women who
generally make health decisions for their families,
24–26
especially with respect to children and their vaccina-
tions, the information obtained from the discussions
may still reflect how households respond to an EID
pandemic.
(3) Data were collected during a non-crisis period and
anticipated risk assessments may differ from those made
during a pandemic. Our findings most likely mirror actual
responses to risks in the early stages of a pandemic when
people may perceive their risks from the disease as low.
Strengths of the study
(1) The study had a novel focus by targeting adults to
explore their attitudes about self-vaccination, rather
than the typical focus on either adults’ attitudes about
vaccinating their children or the elderly’s attitudes about
self-vaccinating (thus capturing attitudes from a vulner-
able population). Although studies have been conducted
on HCWs’ attitudes toward self-vaccination, they have
not been carried out in the context of a pandemic (see
the next point).
(2) The study focused on new vaccines for use against a new
disease. As perceived risks vary with uncertainty, it
cannot be assumed that findings from studies on
attitudes about established vaccines for existing diseases
can be extrapolated to pandemic situations. Our findings
suggest that many vaccine attitudes from non-pandemic
contexts can be applied in a pandemic, and also high-
light concerns that are specific to the novelties of a
pandemic situation. The unanticipated findings include
the extent to which parents said they would vaccinate
themselves but not their children, the perception that
personal control measures can be perceived to be
sufficient protection in a pandemic, thus minimizing
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concern that vaccine safety is compromised during a
pandemic.
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